Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis
X Li, C Liu, Z Mao, M Xiao, L Wang, S Qi, F Zhou - Critical Care, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19), a highly infectious disease,
has been rapidly spreading all over the world and remains a great threat to global public …
has been rapidly spreading all over the world and remains a great threat to global public …
Neutrophil-to-lymphocyte ratio and mortality in the United States general population
The neutrophil-to-lymphocyte ratio (NLR) in peripheral blood reflects the balance between
systemic inflammation and immunity and is emerging as a prognostic biomarker in many …
systemic inflammation and immunity and is emerging as a prognostic biomarker in many …
Neutrophils as emerging protagonists and targets in chronic inflammatory diseases
K Rawat, A Shrivastava - Inflammation Research, 2022 - Springer
Introduction Neutrophils are the key cells of our innate immune system with a primary role in
host defense. They rapidly arrive at the site of infection and display a range of effector …
host defense. They rapidly arrive at the site of infection and display a range of effector …
Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing
Background DNA methylation changes with age. Chronological age predictors built from
DNA methylation are termed 'epigenetic clocks'. The deviation of predicted age from the …
DNA methylation are termed 'epigenetic clocks'. The deviation of predicted age from the …
Whole genome sequence analysis of the plasma proteome in black adults provides novel insights into cardiovascular disease
Background: Plasma proteins are critical mediators of cardiovascular processes and are the
targets of many drugs. Previous efforts to characterize the genetic architecture of the plasma …
targets of many drugs. Previous efforts to characterize the genetic architecture of the plasma …
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab
T Kobayashi, K Ito, T Kojima, M Kato, S Kanda… - Cancer …, 2021 - Wiley Online Library
The use of immune checkpoint inhibitors to treat urothelial carcinoma (UC) is increasing
rapidly without clear guidance for validated risk stratification. This multicenter retrospective …
rapidly without clear guidance for validated risk stratification. This multicenter retrospective …
Dynamic status of SII and SIRI alters the risk of cardiovascular diseases: evidence from kailuan cohort study
J Li, D He, J Yu, S Chen, Q Wu, Z Cheng… - Journal of …, 2023 - Taylor & Francis
Background Two novel systemic inflammation indices, SII and SIRI, are associated with
increased risk of cardiovascular diseases (CVD). However, SII and SIRI are prone to change …
increased risk of cardiovascular diseases (CVD). However, SII and SIRI are prone to change …
Neutrophil‐to‐lymphocyte ratio and outcomes in patients with new‐onset or worsening heart failure with reduced and preserved ejection fraction
Aims Inflammation is thought to play a role in heart failure (HF) pathophysiology. Neutrophil‐
to‐lymphocyte ratio (NLR) is a simple, routinely available measure of inflammation. Its …
to‐lymphocyte ratio (NLR) is a simple, routinely available measure of inflammation. Its …
Neutrophil-lymphocyte ratio in patients with acute heart failure predicts in-hospital and long-term mortality
The application of a simple blood test to predict prognosis in acute heart failure (AHF)
patients is not well established. Neutrophil-lymphocyte ratio (NLR) is inexpensive and easy …
patients is not well established. Neutrophil-lymphocyte ratio (NLR) is inexpensive and easy …
Association of the systemic immune-inflammation index with outcomes in acute coronary syndrome patients with chronic kidney disease
S Shi, S Kong, W Ni, Y Lu, J Li, Y Huang… - Journal of …, 2023 - Taylor & Francis
Background The systemic immune-inflammation index (SII; neutrophil× platelet/lymphocyte)
is a novel marker for immune and inflammatory status and is associated with adverse …
is a novel marker for immune and inflammatory status and is associated with adverse …